Baxter International Inc.
30.61
0.11 (0.36%)
At close: Jan 14, 2025, 3:59 PM
30.62
0.05%
After-hours Jan 14, 2025, 07:00 PM EST

Baxter International Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
Medical Products And Therapies Revenue 272.00M 263.00M 796.00M 255.00M
Medical Products And Therapies Revenue Growth +3.42% -66.96% +212.16% n/a
Healthcare Systems and Technologies Revenue 296.00M 265.00M 912.00M 301.00M
Healthcare Systems and Technologies Revenue Growth +11.70% -70.94% +202.99% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010
Emea Revenue 3.32B 3.71B 3.55B 3.13B 2.97B 2.96B 2.73B 2.70B 2.77B 5.14B 4.60B 6.06B 4.39B 4.19B
Emea Revenue Growth -10.51% +4.42% +13.52% +5.42% +0.24% +8.42% +1.26% -2.78% -45.99% +11.73% -24.09% +37.89% +4.87% n/a
United States Revenue 7.00B 7.22B 5.18B 4.88B 4.83B 4.72B 4.51B 4.26B 4.00B 7.01B 6.45B n/a 5.71B 5.26B
United States Revenue Growth -3.09% +39.44% +6.19% +1.08% +2.18% +4.72% +5.89% +6.45% -42.97% +8.74% n/a n/a +8.45% n/a
Western Europe, Canada, Japan, Australia And New Zealand Revenue 4.49B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Western Europe, Canada, Japan, Australia And New Zealand Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 754.00M 1.02B 857.00M 935.00M 1.00B 964.00M 1.01B 912.00M 942.00M 976.00M 1.05B 885.00M 680.00M 678.00M 627.00M 650.00M 601.00M 590.00M 628.00M 1.42B 627.00M 642.00M 600.00M 629.00M 685.00M 681.00M 622.00M 697.00M 685.00M 635.00M 570.00M 663.00M 726.00M 709.00M 641.00M 733.00M 794.00M 1.10B 1.01B
Selling, General, and Administrative Revenue Growth -26.15% +19.14% -8.34% -6.69% +3.94% -4.55% +10.75% -3.18% -3.48% -7.22% +18.87% +30.15% +0.29% +8.13% -3.54% +8.15% +1.86% -6.05% -55.81% +126.63% -2.34% +7.00% -4.61% -8.18% +0.59% +9.49% -10.76% +1.75% +7.87% +11.40% -14.03% -8.68% +2.40% +10.61% -12.55% -7.68% -27.62% +8.08% n/a
Research and Development Revenue 129.00M 173.00M 160.00M 172.00M 166.00M 165.00M 164.00M 155.00M 152.00M 148.00M 150.00M 138.00M 129.00M 139.00M 128.00M 135.00M 123.00M 117.00M 146.00M 156.00M 144.00M 166.00M 129.00M 175.00M 166.00M 174.00M 140.00M 182.00M 151.00M 156.00M 128.00M 157.00M 159.00M 195.00M 136.00M 161.00M 148.00M 388.00M 300.00M
Research and Development Revenue Growth -25.43% +8.12% -6.98% +3.61% +0.61% +0.61% +5.81% +1.97% +2.70% -1.33% +8.70% +6.98% -7.19% +8.59% -5.19% +9.76% +5.13% -19.86% -6.41% +8.33% -13.25% +28.68% -26.29% +5.42% -4.60% +24.29% -23.08% +20.53% -3.21% +21.88% -18.47% -1.26% -18.46% +43.38% -15.53% +8.78% -61.86% +29.33% n/a